Same Drug Class

Imatinib vs Tofacitinib

Imatinib vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Imatinib and Tofacitinib.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O; Tofacitinib — C16H20N6O.

Molecular Weight: Imatinib — 493.6030 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Imatinib — Small molecule; Tofacitinib — Small molecule.